Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Morales

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Plos Medicine|February 13, 2025
Depression and physical multimorbidity: A cohort study of physical health condition accrual in UK BiobankKelly J Fleetwood, Bruce Guthrie, Caroline A Jackson, et al.
British Journal of Clinical Pharmacology|March 31, 2024
Impact of the early COVID-19 pandemic on adult mental health-related dispensed medications, hospitalizations and specialist outpatient visits in Norway and Sweden: Interrupted time series analysisDavid Moreno-Martos, Jing Zhao, Huiqi Li, et al.
BMJ (Clinical Research Ed.)|April 17, 2024
Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort studyPearl L H Mok, Matthew J Carr, Bruce Guthrie, et al.
Pharmacoepidemiology and Drug Safety|September 5, 2024
Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming CodeJohn Tazare, Shirley V Wang, Rosa Gini, et al.
Pharmacoepidemiology and Drug Safety|February 14, 2025
Expanding the OMOP Common Data Model to Support Perinatal Research in Network StudiesAlicia Abellan, Edward Burn, Nhung T H Trinh, et al.
BMC Medicine|November 27, 2025
Assessing the representativeness of trials of Sodium-glucose Cotransporter-2 inhibitors in type 2 diabetes: a comparison of individual-level trial data and people newly prescribed treatment in a Welsh routine care databasePeter Hanlon, Heather Wightman, Michael Sullivan, et al.
Scientific Reports|May 15, 2026
Venous and arterial thromboembolic events after COVID-19 during the Omicron period in three European countriesXintong Li, Annika M Jödicke, Albert Prats-Uribe, et al.
Pharmacoepidemiology and Drug Safety|February 22, 2022
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countriesEdward Burn, Xintong Li, Kristin Kostka, et al.
Diabetes Care|March 21, 2023
Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety StudyHuan Wang, Ruth L M Cordiner, Yu Huang, et al.
Pharmacoepidemiology and Drug Safety|January 2, 2021
Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysisDaniel R Morales, Tatiana Macfarlane, Thomas M MacDonald, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Plos Medicine|February 13, 2025
Depression and physical multimorbidity: A cohort study of physical health condition accrual in UK BiobankKelly J Fleetwood, Bruce Guthrie, Caroline A Jackson, et al.
British Journal of Clinical Pharmacology|March 31, 2024
Impact of the early COVID-19 pandemic on adult mental health-related dispensed medications, hospitalizations and specialist outpatient visits in Norway and Sweden: Interrupted time series analysisDavid Moreno-Martos, Jing Zhao, Huiqi Li, et al.
BMJ (Clinical Research Ed.)|April 17, 2024
Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort studyPearl L H Mok, Matthew J Carr, Bruce Guthrie, et al.
Pharmacoepidemiology and Drug Safety|September 5, 2024
Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming CodeJohn Tazare, Shirley V Wang, Rosa Gini, et al.
Pharmacoepidemiology and Drug Safety|February 14, 2025
Expanding the OMOP Common Data Model to Support Perinatal Research in Network StudiesAlicia Abellan, Edward Burn, Nhung T H Trinh, et al.
BMC Medicine|November 27, 2025
Assessing the representativeness of trials of Sodium-glucose Cotransporter-2 inhibitors in type 2 diabetes: a comparison of individual-level trial data and people newly prescribed treatment in a Welsh routine care databasePeter Hanlon, Heather Wightman, Michael Sullivan, et al.
Scientific Reports|May 15, 2026
Venous and arterial thromboembolic events after COVID-19 during the Omicron period in three European countriesXintong Li, Annika M Jödicke, Albert Prats-Uribe, et al.
Pharmacoepidemiology and Drug Safety|February 22, 2022
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countriesEdward Burn, Xintong Li, Kristin Kostka, et al.
Diabetes Care|March 21, 2023
Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety StudyHuan Wang, Ruth L M Cordiner, Yu Huang, et al.
Pharmacoepidemiology and Drug Safety|January 2, 2021
Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysisDaniel R Morales, Tatiana Macfarlane, Thomas M MacDonald, et al.
Pageof 12